Immediate Impact

70 standout
Sub-graph 1 of 24

Citing Papers

Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 Standout
3 intermediate papers

Works of M Janícek being referenced

Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cells
1997
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.
1995

Author Peers

Author Last Decade Papers Cites
M Janícek 94 108 10 165 100 12 306
Walid A. Hindo 134 75 46 30 58 10 297
Raffaella Cerqua 138 21 48 106 26 17 342
Giovanni Frezza 56 100 9 167 59 16 321
Roy J. Reinten 83 85 29 119 24 11 354
James P. Bolling 31 27 45 38 104 17 317
Awni Musharbash 44 57 39 39 28 19 330
O. Switsers 123 169 5 56 140 17 334
Dogan M. Perese 88 45 46 41 24 18 284
Marcus M. Kessler 18 100 47 70 62 12 359
R Hoyt 41 89 11 111 22 13 296

All Works

Loading papers...

Rankless by CCL
2026